3.60
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ERAS Giù?
Forum
Previsione
Erasca Inc Borsa (ERAS) Ultime notizie
Discovering Opportunities: AirJoule Technologies Among 3 Promising Penny Stocks - simplywall.st
Aug Breakouts: Is Erasca Inc stock a buy for dividend growthEarnings Growth Report & AI Optimized Trading Strategy Guides - moha.gov.vn
Platform Technologies Drive $211B Surge in Precision Cancer Treatment - marketscreener.com
Mizuho Maintains Erasca (ERAS) Outperform Recommendation - Nasdaq
Check Out Erasca Inc (ERAS)’s Trade Data Rather Than the Analysts’ Views - Setenews
Mizuho raises Erasca stock price target to $5 on RAS space optimism - Investing.com Canada
Erasca price target raised to $5 from $4 at Mizuho - TipRanks
Erasca, Inc. (NASDAQ:ERAS) Given Average Rating of "Hold" by Analysts - MarketBeat
Affinity Asset Advisors LLC Grows Stock Holdings in Erasca, Inc. $ERAS - Defense World
Will Erasca Inc. stock outperform international peers2025 Top Gainers & Fast Gaining Stock Reports - Newser
Gitlab, Acadia Healthcare, Box And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results - Insider Monkey
Moving Averages: Why Erasca Inc. stock could be next big winnerInsider Buying & Momentum Based Trading Signals - moha.gov.vn
Unusually active option classes on open October 8th - MSN
Erasca to Present at the 8th Annual Evercore Healthcare Conference - The Manila Times
Adversity is less terrifying than hope: Erasca Inc (ERAS) - Setenews
Understanding Erasca Inc.’s price movementPortfolio Risk Summary & High Yield Equity Trading Tips - newser.com
Will Erasca Inc. stock benefit from automation2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Erasca Inc. stock chart pattern explainedJuly 2025 Market Mood & Safe Swing Trade Setups - newser.com
Why Erasca Inc. stock remains on watchlistsWeekly Stock Analysis & Free Weekly Watchlist of Top Performers - newser.com
Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B - GlobeNewswire
ErascaTargeting Cancer's Most Commonly Mutated Pathway - RTTNews
Analyzing Precision BioSciences (NASDAQ:DTIL) and Erasca (NASDAQ:ERAS) - Defense World
HC Wainwright Issues Optimistic Estimate for Erasca Earnings - Defense World
Heatmap analysis for Erasca Inc. and competitorsEarnings Overview Summary & Short-Term Swing Trade Alerts - newser.com
Analyzing net buyer seller activity in Erasca Inc.July 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Using fundamentals and technicals on Erasca Inc.IPO Watch & Risk Managed Investment Signals - newser.com
HC Wainwright Comments on Erasca’s Q1 Earnings (NASDAQ:ERAS) - Defense World
Why Erasca Inc. stock could see breakout soonTrade Performance Summary & AI Optimized Trade Strategies - newser.com
Is Erasca Inc. stock poised for growthQuarterly Growth Report & Weekly Top Performers Watchlists - newser.com
Erasca, Inc. Reports Q3 2025 Financial Results - MSN
Guggenheim raises Erasca stock price target to $5 on pipeline progress By Investing.com - Investing.com South Africa
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):